Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Sheng‐Xiang Rao"'
Autor:
Feng‐Hua Wang, Xiao‐Tian Zhang, Lei Tang, Qi Wu, Mu‐Yan Cai, Yuan‐Fang Li, Xiu‐Juan Qu, Hong Qiu, Yu‐Jing Zhang, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Chang Wang, Hao Liu, Miao‐Zhen Qiu, Wen‐Long Guan, Sheng‐Xiang Rao, Jia‐Fu Ji, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Zhi‐Wei Zhou, Ai‐Ping Zhou, Jing Jin, Xiang‐Lin Yuan, Feng Bi, Tian‐Shu Liu, Han Liang, Yan‐Qiao Zhang, Guo‐Xin Li, Jun Liang, Bao‐Rui Liu, Lin Shen, Jin Li, Rui‐Hua Xu
Publikováno v:
Cancer Communications, Vol 44, Iss 1, Pp 127-172 (2024)
Abstract The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence‐based medicine, heal
Externí odkaz:
https://doaj.org/article/ddb71d41f751472a92fb64e883303e66
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: A number of patients with Crohn’s disease (CD) suffer from loss of response to infliximab (IFX) therapy. Splenic volume is reported to be enlarged in patients with CD compared to normal individuals. The association between splenic volum
Externí odkaz:
https://doaj.org/article/36f1eb5c6e3c47ed9365f7dced3e6208
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background To compare potential of ultrashort time-to-echo (UTE) T2* mapping and T2* values from T2*-weighted imaging for assessing lumbar intervertebral disc degeneration (IVDD),with Pfirrmann grading as a reference standard. Methods UTE-T2
Externí odkaz:
https://doaj.org/article/5ee6a2c0e67d4aa4b6ee39b16b17747b
Publikováno v:
Diagnostic and Interventional Radiology, Vol 28, Iss 3, Pp 193-199 (2022)
PURPOSEWe aimed to assess the performance of quantitative 3D shape analysis in the differential diagno- sis of pancreatic serous oligocystic adenoma (SOA) and mucinous cystic neoplasm (MCN).METHODSFour hundred thirty-two patients diagnosed with serou
Externí odkaz:
https://doaj.org/article/aaef22595e3045f7b013f1b983d77808
Autor:
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, Jia-Yan Yan, Yu-Peng Wang, Ya Cao, Sheng-Xiang Rao, Jia Fan, Xin-Rong Yang, Ao Huang, Jian Zhou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundImmune checkpoint inhibitor (ICI)-based combination therapy has opened a new avenue for the treatment of multiple malignancies including hepatocellular carcinoma (HCC). However, considering the unsatisfactory efficacy, biomarkers are urgent
Externí odkaz:
https://doaj.org/article/b408a1ff6a804c38932bd524141c85a0
Autor:
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, Jia-Yan Yan, Yu-Peng Wang, Ya Cao, Sheng-Xiang Rao, Jia Fan, Xin-Rong Yang, Ao Huang, Jian Zhou
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundLenvatinib monotherapy and combination therapy with immune checkpoint inhibitors (ICI) were widely applied for unresectable hepatocellular carcinoma (uHCC). However, many patients failed to benefit from the treatments. A prognostic model wa
Externí odkaz:
https://doaj.org/article/56079ece69b04b749806519d91bd529f
Autor:
Bin Xu, Sanyuan Dong, Xue-Li Bai, Tian-Qiang Song, Bo-Heng Zhang, Le-Du Zhou, Yong-Jun Chen, Zhi-Ming Zeng, Kui Wang, Hai-Tao Zhao, Na Lu, Wei Zhang, Xu-Bin Li, Su-Su Zheng, Guo Long, Yu-Chen Yang, Hua-Sheng Huang, Lan-Qing Huang, Yun-Chao Wang, Fei Liang, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Jian Zhou, Meng-Su Zeng, Jia Fan, Sheng-Xiang Rao, Hui-Chuan Sun
Publikováno v:
Liver Cancer (2022)
Introduction: Lenvatinib plus an anti–PD-1 antibody has shown promising anti-tumor effects in patients with advanced hepatocellular carcinoma (HCC), but with clinical benefit limited to a subset of patients. We developed and validated a radiomic-ba
Externí odkaz:
https://doaj.org/article/8ffc70f4b79c4d9794e9ade6e626e051
Autor:
Feng‐Hua Wang, Xiao‐Tian Zhang, Yuan‐Fang Li, Lei Tang, Xiu‐Juan Qu, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Hong Qiu, Chang Wang, Miao‐Zhen Qiu, Mu‐Yan Cai, Qi Wu, Hao Liu, Wen‐Long Guan, Ai‐Ping Zhou, Yu‐Jing Zhang, Tian‐Shu Liu, Feng Bi, Xiang‐Lin Yuan, Sheng‐Xiang Rao, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Guo‐Xin Li, Jia‐Fu Ji, Zhi‐Wei Zhou, Han Liang, Yan‐Qiao Zhang, Jing Jin, Lin Shen, Jin Li, Rui‐Hua Xu
Publikováno v:
Cancer Communications, Vol 41, Iss 8, Pp 747-795 (2021)
Abstract There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries. T
Externí odkaz:
https://doaj.org/article/25078e83af624f808e27aec19309390f
Publikováno v:
Diagnostic and Interventional Radiology, Vol 26, Iss 5, Pp 396-402 (2020)
PURPOSEWe aimed to evaluate which morphologic features on magnetic resonance imaging (MRI) could predict the progression of pancreatic cystic lesions (PCLs) that are suitable for follow-up.METHODSA total of 2176 MRI findings of PCLs were retrospectiv
Externí odkaz:
https://doaj.org/article/41febf537052452db83232a0ede1dcb8
Autor:
Shuo Zhu, Wen-Tao Wang, Xiao-Sha Shang, Ting Ni, Wen-Chuan Wu, Wen-Hui Lou, Meng-Su Zeng, Sheng-Xiang Rao
Publikováno v:
BMC Medical Imaging, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The purpose was to investigate the difference of detection rate of incidental pancreatic cystic lesions (PCLs) with computed tomography (CT) and magnetic resonance imaging (MRI) and to compare the difference between CT and MRI and
Externí odkaz:
https://doaj.org/article/652b12aaa84e48a389c5e9111913a6c1